Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been making waves in the biopharmaceutical industry with its strong portfolio of ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Shares of Eli Lilly & Co. LLY rallied 1.34% to $771.71 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,296.79 and ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

Given this positive news and the subsequent stock rise, the question is whether Eli Lilly is a buy at around $820. Our analysis suggests it is.

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

I recommend buying Eli Lilly and Company stock after strong Q2 earnings, with technical indicators pointing to upward momentum. Click for more on LLY stock.

Eli Lilly shares hit a record high on Tuesday after announcing that clinical trials showed that one of its drugs significantly lowers the risk of developing type 2 diabetes. Monitor these ...

Eli Lilly (LLY -3.37%) has a strong pipeline of new medicines that could increase the stock price. *Stock prices used were the afternoon prices of May 15, 2025.